Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.
Ji-Won KimJun Sik YoonSojeong ParkHasung KimJi Sung LeeJung-Yoon ChoePublished in: Annals of the rheumatic diseases (2024)
In a real-world AS cohort, higher dose of NSAID treatment was associated with a higher risk of CVD, including ischaemic heart disease, stroke and congestive heart failure.
Keyphrases
- anti inflammatory drugs
- ankylosing spondylitis
- high dose
- low dose
- heart failure
- cardiovascular disease
- atrial fibrillation
- rheumatoid arthritis
- disease activity
- stem cell transplantation
- type diabetes
- pulmonary hypertension
- left ventricular
- metabolic syndrome
- systemic lupus erythematosus
- combination therapy
- coronary artery disease